A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical Condition

University of Maryland, Baltimore100 enrolled

Overview

This study will develop and evaluate the effectiveness of a self-management program for adults living with both schizophrenia and a co-occurring medical condition.

Schizophrenia is a life-long brain disorder affecting approximately 1 percent of Americans each year. Schizophrenia can be extremely disabling, causing people to hear voices, experience paranoia or hallucinations, and believe that others are controlling their thoughts. People with schizophrenia also experience increased rates of concurrent medical conditions, such as diabetes, respiratory illness, and heart disease. This can make holding a job or even caring for oneself very difficult. The purpose of this study is to develop and evaluate a self-management program for adults living with both schizophrenia and a concurrent medical condition. Participants in this open-label study will attend 10 to 16 group sessions led by two group leaders. Group sessions will meet each week for an hour during which participants will learn new skills to help them take responsibility for the daily management of chronic medical conditions. In addition to learning how to communicate more effectively with medical providers, participants will learn about healthy eating, the importance of physical activity, addictive behaviors that can worsen health conditions, and proper use of medications. Homework will be assigned weekly for participants to review skills learned in each session. After each session, participants will complete a survey to evaluate the session's effectiveness. At the end of the study, participants will attend one additional group meeting and an individual interview to discuss the overall effectiveness of the intervention and their experiences in the group sessions. The results of this study will be used to evaluate and improve the self-management program for future use.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

100

Conditions

Schizophrenia

Interventions

Self-management program for chronic illnessBEHAVIORAL

Self-management program for chronic illness will include between 10 and 16 psychoeducational and supportive group sessions.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 64 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Meets DSM-IV criteria for schizophrenia or schizoaffective disorder * Current documented chart diagnosis of at least one chronic medical condition * Received clinic services for a minimum of 3 months prior to study entry * English-speaking * Willing to use an effective form of birth control throughout the study if sexually active Exclusion Criteria: * History of a serious neurological disorder or head trauma with loss of consciousness * Diagnosed with mental retardation or dementia * Diagnosed with end stage organ disease * Currently receiving chemotherapy and/or radiation treatment for cancer * Received psychiatric hospitalization less than 3 months prior to study entry date * Blind and/or deaf * Pregnant * Infected with HIV with a CD4 count under 350 * Diagnosis of AIDS * Diagnosis of anorexia * Problematic substance use, as defined by a mental health provider * Psychiatric instability, as defined by a mental health provider

Locations (1)

Fayette Street Clinics

Baltimore, Maryland, United States

Outcomes

Primary Outcomes

Health-related self-efficacy and recovery orientation

Time frame: Measured at pre- and post-intervention

Medical illness self-management skills

Time frame: Measured at pre- and post-intervention

Social and communication skills during interactions with health care providers

Time frame: Measured at pre- and post-intervention

Physical and mental health status

Time frame: Measured at pre- and post-intervention

Medical service use patterns

Time frame: Measured at pre- and post-intervention

Secondary Outcomes

Medication use

Time frame: Measured throughout the study

Neurocognition

Time frame: Measured at baseline

Substance abuse

Time frame: Measured at pre- and post-intervention

Psychiatric symptoms

Time frame: Measured at pre- and post-intervention

Amount and seriousness of related comorbidities

Time frame: Measured at pre- and post-intervention

Quantitative and qualitative survey ratings

Time frame: Measured throughout the study

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.